Cardiac Troponin Market Size to Hit USD 10.51 Billion by 2034

Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis

4.3.2. Sales and Distribution Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. COVID 19 Impact on Cardiac Troponin Market

5.1. COVID-19 Landscape: Cardiac Troponin Industry Impact

5.2. COVID 19 - Impact Assessment for the Industry

5.3. COVID 19 Impact: Global Major Government Policy

5.4. Market Trends and Opportunities in the COVID-19 Landscape

Chapter 6. Market Dynamics Analysis and Trends

6.1. Market Dynamics

6.1.1. Market Drivers

6.1.2. Market Restraints

6.1.3. Market Opportunities

6.2. Porter’s Five Forces Analysis

6.2.1. Bargaining power of suppliers

6.2.2. Bargaining power of buyers

6.2.3. Threat of substitute

6.2.4. Threat of new entrants

6.2.5. Degree of competition

Chapter 7. Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis

7.1.2. Key Strategies Adopted by Players

7.1.3. Vendor Landscape

7.1.3.1. List of Suppliers

7.1.3.2. List of Buyers

Chapter 8. Global Cardiac Troponin Market, By Type

8.1. Cardiac Troponin Market Revenue and Volume, by Type

8.1.1. Troponin I (cTnI)

8.1.1.1. Market Revenue and Volume Forecast

8.1.2. Troponin T (cTnT)

8.1.2.1. Market Revenue and Volume Forecast

8.1.3. Troponin C (cTnC)

8.1.3.1. Market Revenue and Volume Forecast

8.1.4. Others (e.g., high-sensitivity multi-marker combinations)

8.1.4.1. Market Revenue and Volume Forecast

Chapter 9. Global Cardiac Troponin Market, By Sample Type

9.1. Cardiac Troponin Market Revenue and Volume, by Sample Type

9.1.1. Whole Blood

9.1.1.1. Market Revenue and Volume Forecast

9.1.2. Plasma

9.1.2.1. Market Revenue and Volume Forecast

9.1.2. Serum

9.1.2.1. Market Revenue and Volume Forecast

9.1.2. Others (e.g., fingerstick samples)

9.1.2.1. Market Revenue and Volume Forecast

Chapter 10. Global Cardiac Troponin Market, By Technology

10.1. Cardiac Troponin Market Revenue and Volume, by Technology

10.1.1. Chemiluminescence Immunoassay (CLIA)

10.1.1.1. Market Revenue and Volume Forecast

10.1.2. Immunofluorescence Assay (IFA)

10.1.2.1. Market Revenue and Volume Forecast

10.1.3. Enzyme-Linked Immunosorbent Assay (ELISA)

10.1.3.1. Market Revenue and Volume Forecast

10.1.4. Radioimmunoassay (RIA)

10.1.4.1. Market Revenue and Volume Forecast

10.1.5. Others (e.g., biosensors, electrochemical assays)

10.1.5.1. Market Revenue and Volume Forecast

Chapter 11. Global Cardiac Troponin Market, By End Use

11.1. Cardiac Troponin Market Revenue and Volume, by End Use

11.1.1. Hospitals & Clinics

11.1.1.1. Market Revenue and Volume Forecast

11.1.2. Diagnostic Laboratories

11.1.2.1. Market Revenue and Volume Forecast

11.1.3. Ambulatory Surgical Centers (ASCs)

11.1.3.1. Market Revenue and Volume Forecast

11.1.4. Homecare Settings

11.1.4.1. Market Revenue and Volume Forecast

11.1.5. Others (e.g., academic & research institutions)

11.1.5.1. Market Revenue and Volume Forecast

Chapter 12. Global Cardiac Troponin Market, By Application

12.1. Cardiac Troponin Market Revenue and Volume, by Application

12.1.1. Myocardial Infarction Diagnosis

12.1.1.1. Market Revenue and Volume Forecast

12.1.2. Congestive Heart Failure Monitoring

12.1.2.1. Market Revenue and Volume Forecast

12.1.3. Acute Coronary Syndrome (ACS) Risk Stratification

12.1.3.1. Market Revenue and Volume Forecast

12.1.4. Others (e.g., perioperative risk assessment, myocarditis)

12.1.4.1. Market Revenue and Volume Forecast

Chapter 13. Global Cardiac Troponin Market, By Test Type

13.1. Cardiac Troponin Market Revenue and Volume, by Test Type

13.1.1. Laboratory-Based Testing

13.1.1.1. Market Revenue and Volume Forecast

13.1.2. Point-of-Care Testing (POCT)

13.1.2.1. Market Revenue and Volume Forecast

13.1.3. Others

13.1.3.1. Market Revenue and Volume Forecast

Chapter 14. Global Cardiac Troponin Market, Regional Estimates and Trend Forecast

14.1. North America

14.1.1. Market Revenue and Volume Forecast, by Type

14.1.2. Market Revenue and Volume Forecast, by Sample Type

14.1.3. Market Revenue and Volume Forecast, by Technology

14.1.4. Market Revenue and Volume Forecast, by End Use

14.1.5. Market Revenue and Volume Forecast, by Application

14.1.6. Market Revenue and Volume Forecast, by Test Type

14.1.7. U.S.

14.1.7.1. Market Revenue and Volume Forecast, by Type

14.1.7.2. Market Revenue and Volume Forecast, by Sample Type

14.1.7.3. Market Revenue and Volume Forecast, by Technology

14.1.7.4. Market Revenue and Volume Forecast, by End Use

14.1.8. Market Revenue and Volume Forecast, by Application

14.1.8.1. Market Revenue and Volume Forecast, by Test Type

14.1.9. Rest of North America

14.1.9.1. Market Revenue and Volume Forecast, by Type

14.1.9.2. Market Revenue and Volume Forecast, by Sample Type

14.1.9.3. Market Revenue and Volume Forecast, by Technology

14.1.9.4. Market Revenue and Volume Forecast, by End Use

14.1.10. Market Revenue and Volume Forecast, by Application

14.1.11. Market Revenue and Volume Forecast, by Test Type

14.1.11.1.

14.2. Europe

14.2.1. Market Revenue and Volume Forecast, by Type

14.2.2. Market Revenue and Volume Forecast, by Sample Type

14.2.3. Market Revenue and Volume Forecast, by Technology

14.2.4. Market Revenue and Volume Forecast, by End Use

14.2.5. Market Revenue and Volume Forecast, by Application

14.2.6. Market Revenue and Volume Forecast, by Test Type

14.2.7.

14.2.8. UK

14.2.8.1. Market Revenue and Volume Forecast, by Type

14.2.8.2. Market Revenue and Volume Forecast, by Sample Type

14.2.8.3. Market Revenue and Volume Forecast, by Technology

14.2.9. Market Revenue and Volume Forecast, by End Use

14.2.10. Market Revenue and Volume Forecast, by Application

14.2.10.1. Market Revenue and Volume Forecast, by Test Type

14.2.11. Germany

14.2.11.1. Market Revenue and Volume Forecast, by Type

14.2.11.2. Market Revenue and Volume Forecast, by Sample Type

14.2.11.3. Market Revenue and Volume Forecast, by Technology

14.2.12. Market Revenue and Volume Forecast, by End Use

14.2.13. Market Revenue and Volume Forecast, by Application

14.2.14. Market Revenue and Volume Forecast, by Test Type

14.2.14.1.

14.2.15. France

14.2.15.1. Market Revenue and Volume Forecast, by Type

14.2.15.2. Market Revenue and Volume Forecast, by Sample Type

14.2.15.3. Market Revenue and Volume Forecast, by Technology

14.2.15.4. Market Revenue and Volume Forecast, by End Use

14.2.16. Market Revenue and Volume Forecast, by Application

14.2.16.1. Market Revenue and Volume Forecast, by Test Type

14.2.17. Rest of Europe

14.2.17.1. Market Revenue and Volume Forecast, by Type

14.2.17.2. Market Revenue and Volume Forecast, by Sample Type

14.2.17.3. Market Revenue and Volume Forecast, by Technology

14.2.17.4. Market Revenue and Volume Forecast, by End Use

14.2.18. Market Revenue and Volume Forecast, by Application

14.2.18.1. Market Revenue and Volume Forecast, by Test Type

14.3. APAC

14.3.1. Market Revenue and Volume Forecast, by Type

14.3.2. Market Revenue and Volume Forecast, by Sample Type

14.3.3. Market Revenue and Volume Forecast, by Technology

14.3.4. Market Revenue and Volume Forecast, by End Use

14.3.5. Market Revenue and Volume Forecast, by Application

14.3.6. Market Revenue and Volume Forecast, by Test Type

14.3.7. India

14.3.7.1. Market Revenue and Volume Forecast, by Type

14.3.7.2. Market Revenue and Volume Forecast, by Sample Type

14.3.7.3. Market Revenue and Volume Forecast, by Technology

14.3.7.4. Market Revenue and Volume Forecast, by End Use

14.3.8. Market Revenue and Volume Forecast, by Application

14.3.9. Market Revenue and Volume Forecast, by Test Type

14.3.10. China

14.3.10.1. Market Revenue and Volume Forecast, by Type

14.3.10.2. Market Revenue and Volume Forecast, by Sample Type

14.3.10.3. Market Revenue and Volume Forecast, by Technology

14.3.10.4. Market Revenue and Volume Forecast, by End Use

14.3.11. Market Revenue and Volume Forecast, by Application

14.3.11.1. Market Revenue and Volume Forecast, by Test Type

14.3.12. Japan

14.3.12.1. Market Revenue and Volume Forecast, by Type

14.3.12.2. Market Revenue and Volume Forecast, by Sample Type

14.3.12.3. Market Revenue and Volume Forecast, by Technology

14.3.12.4. Market Revenue and Volume Forecast, by End Use

14.3.12.5. Market Revenue and Volume Forecast, by Application

14.3.12.6. Market Revenue and Volume Forecast, by Test Type

14.3.13. Rest of APAC

14.3.13.1. Market Revenue and Volume Forecast, by Type

14.3.13.2. Market Revenue and Volume Forecast, by Sample Type

14.3.13.3. Market Revenue and Volume Forecast, by Technology

14.3.13.4. Market Revenue and Volume Forecast, by End Use

14.3.13.5. Market Revenue and Volume Forecast, by Application

14.3.13.6. Market Revenue and Volume Forecast, by Test Type

14.4. MEA

14.4.1. Market Revenue and Volume Forecast, by Type

14.4.2. Market Revenue and Volume Forecast, by Sample Type

14.4.3. Market Revenue and Volume Forecast, by Technology

14.4.4. Market Revenue and Volume Forecast, by End Use

14.4.5. Market Revenue and Volume Forecast, by Application

14.4.6. Market Revenue and Volume Forecast, by Test Type

14.4.7. GCC

14.4.7.1. Market Revenue and Volume Forecast, by Type

14.4.7.2. Market Revenue and Volume Forecast, by Sample Type

14.4.7.3. Market Revenue and Volume Forecast, by Technology

14.4.7.4. Market Revenue and Volume Forecast, by End Use

14.4.8. Market Revenue and Volume Forecast, by Application

14.4.9. Market Revenue and Volume Forecast, by Test Type

14.4.10. North Africa

14.4.10.1. Market Revenue and Volume Forecast, by Type

14.4.10.2. Market Revenue and Volume Forecast, by Sample Type

14.4.10.3. Market Revenue and Volume Forecast, by Technology

14.4.10.4. Market Revenue and Volume Forecast, by End Use

14.4.11. Market Revenue and Volume Forecast, by Application

14.4.12. Market Revenue and Volume Forecast, by Test Type

14.4.13. South Africa

14.4.13.1. Market Revenue and Volume Forecast, by Type

14.4.13.2. Market Revenue and Volume Forecast, by Sample Type

14.4.13.3. Market Revenue and Volume Forecast, by Technology

14.4.13.4. Market Revenue and Volume Forecast, by End Use

14.4.13.5. Market Revenue and Volume Forecast, by Application

14.4.13.6. Market Revenue and Volume Forecast, by Test Type

14.4.14. Rest of MEA

14.4.14.1. Market Revenue and Volume Forecast, by Type

14.4.14.2. Market Revenue and Volume Forecast, by Sample Type

14.4.14.3. Market Revenue and Volume Forecast, by Technology

14.4.14.4. Market Revenue and Volume Forecast, by End Use

14.4.14.5. Market Revenue and Volume Forecast, by Application

14.4.14.6. Market Revenue and Volume Forecast, by Test Type

14.5. Latin America

14.5.1. Market Revenue and Volume Forecast, by Type

14.5.2. Market Revenue and Volume Forecast, by Sample Type

14.5.3. Market Revenue and Volume Forecast, by Technology

14.5.4. Market Revenue and Volume Forecast, by End Use

14.5.5. Market Revenue and Volume Forecast, by Application

14.5.6. Market Revenue and Volume Forecast, by Test Type

14.5.7. Brazil

14.5.7.1. Market Revenue and Volume Forecast, by Type

14.5.7.2. Market Revenue and Volume Forecast, by Sample Type

14.5.7.3. Market Revenue and Volume Forecast, by Technology

14.5.7.4. Market Revenue and Volume Forecast, by End Use

14.5.8. Market Revenue and Volume Forecast, by Application

14.5.8.1. Market Revenue and Volume Forecast, by Test Type

14.5.9. Rest of LATAM

14.5.9.1. Market Revenue and Volume Forecast, by Type

14.5.9.2. Market Revenue and Volume Forecast, by Sample Type

14.5.9.3. Market Revenue and Volume Forecast, by Technology

14.5.9.4. Market Revenue and Volume Forecast, by End Use

14.5.9.5. Market Revenue and Volume Forecast, by Application

14.5.9.6. Market Revenue and Volume Forecast, by Test Type

Chapter 15. Company Profiles

15.1. Siemens Healthineers

15.1.1. Company Overview

15.1.2. Product Offerings

15.1.3. Financial Performance

15.1.4. Recent Initiatives

15.2. bioMérieux SA

15.2.1. Company Overview

15.2.2. Product Offerings

15.2.3. Financial Performance

15.2.4. Recent Initiatives

15.3. Bio-Rad Laboratories

15.3.1. Company Overview

15.3.2. Product Offerings

15.3.3. Financial Performance

15.3.4. Recent Initiatives

15.4. LSI Medience Corporation

15.4.1. Company Overview

15.4.2. Product Offerings

15.4.3. Financial Performance

15.4.4. Recent Initiatives

15.5. Tosoh Corporation

15.5.1. Company Overview

15.5.2. Product Offerings

15.5.3. Financial Performance

15.5.4. Recent Initiatives

15.6. Shenzhen Mindray Bio-Medical Electronics Co., Ltd.

15.6.1. Company Overview

15.6.2. Product Offerings

15.6.3. Financial Performance

15.6.4. Recent Initiatives

15.7. HyTest Ltd

15.7.1. Company Overview

15.7.2. Product Offerings

15.7.3. Financial Performance

15.7.4. Recent Initiatives

15.8. Response Biomedical Corp.

15.8.1. Company Overview

15.8.2. Product Offerings

15.8.3. Financial Performance

15.8.4. Recent Initiatives

15.9. Getein Biotech Inc.

15.9.1. Company Overview

15.9.2. Product Offerings

15.9.3. Financial Performance

15.9.4. Recent Initiatives

15.10. LifeSign LLC

15.10.1. Company Overview

15.10.2. Product Offerings

15.10.3. Financial Performance

15.10.4. Recent Initiatives

Chapter 16. Research Methodology

16.1. Primary Research

16.2. Secondary Research

16.3. Assumptions

Chapter 17. Appendix

17.1. About Us

17.2. Glossary of Terms

For questions or customization requests, please reach out to us at sales@precedenceresearch.com

Frequently Asked Questions

The cardiac troponin market size is expected to increase from USD 3.89 billion in 2024 to USD 10.51 billion by 2034.

The cardiac troponin market is expected to grow at a compound annual growth rate (CAGR) of around 10.45% from 2025 to 2034.

The major players in the cardiac troponin market include Abbott Laboratories, Roche Diagnostics, Siemens Healthineers, Beckman Coulter, bioMérieux SA, Ortho Clinical Diagnostics, Becton, Dickinson and Company (BD), Radiometer Medical (Danaher), Bio-Rad Laboratories, LSI Medience Corporation, Tosoh Corporation, Randox Laboratories, Thermo Fisher Scientific, Shenzhen Mindray Bio-Medical Electronics Co., Ltd., Singulex, Inc., HyTest Ltd, Response Biomedical Corp., Getein Biotech Inc., LifeSign LLC, and Creative Diagnostics.

The driving factors of the cardiac troponin market are the rising incidence of heart attacks and other cardiac-related disorders around the globe is increasing the demand for reliable biomarkers such as troponins so that early diagnosis and effective clinical response can occur.

North America region will lead the global cardiac troponin market during the forecast period 2025 to 2034.